Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Aug 26, 2021
Date Accepted: Jan 7, 2022

The final, peer-reviewed published version of this preprint can be found here:

Digital Health Technologies to Improve Medication Adherence and Treatment Outcomes in Patients With Tuberculosis: Systematic Review of Randomized Controlled Trials

Ridho A, Alfian SD, van Boven J, Levita J, Aki Yalcin E, Le L, Alffenaar JW, Hak E, Abdulah R, Pradipta IS

Digital Health Technologies to Improve Medication Adherence and Treatment Outcomes in Patients With Tuberculosis: Systematic Review of Randomized Controlled Trials

J Med Internet Res 2022;24(2):e33062

DOI: 10.2196/33062

PMID: 35195534

PMCID: 8908199

Digital Health Technologies to Improve Medication Adherence and Treatment Outcomes in Tuberculosis Patients: A Systematic Review of Randomized Controlled Studies

  • Abdurahman Ridho; 
  • Sofa Dewi Alfian; 
  • Job van Boven; 
  • Jutti Levita; 
  • Esin Aki Yalcin; 
  • Ly Le; 
  • Jan-Willem Alffenaar; 
  • Eelko Hak; 
  • Rizky Abdulah; 
  • Ivan Surya Pradipta

ABSTRACT

Background:

Non-adherence to medication in tuberculosis (TB) hampers optimal treatment outcomes. Digital health technology (DHT) seems to be a promising approach to managing problems of non-adherence to medication and improving treatment

Objective:

This article aimed to systematically review the effect of DHT to improve medication adherence and treatment outcomes in patients with TB.

Methods:

A literature search in PubMed and Cochrane databases was performed. We included Randomized Controlled Trials (RCT) that analyzed the effect of DHT interventions in improving adherence to medication and treatment success. Adult TB patients with either active or latent TB infection were included. The JADAD score was used for assessing the quality of the studies. We followed PRISMA to report our findings.

Results:

Sixteen RCTs were selected from 552 studies found. Sixth types of DHT interventions were identified. Several interventions demonstrated positive effects in completing treatment, i.e., video directly observed therapy (VDOT) (Relative Risk (RR) 1.36; 95% Confidence Interval (CI) 1.19-1.55), video observed therapy (VOT) (Odds Ratio (OR) 2.52; 95% CI 1.17-5.54), ingestible sensor (OR 7.69; 95% CI 4.51-14.48), and SMS reminder (RR 1.1; 95% CI 1.04-1.18; RR 1.05; 95% CI 1.04–1.06; OR 2.472; 95% CI 1.133-5.434), while medication monitor box interventions showed protective effects in missing dose of TB medication (Mean Ratio (MR) 0.58; 95% CI 0.42-0.79; MR 0.49; 95% CI 0.27-0.88). However several studies showed the different effects in completing treatment, i.e., VDOT (RR 0.99; 95% CI 0.93-1.05; RR 1.08; 95% CI 0.89-1.32), medication monitor box (RR 0.55; 95% CI 0.21-1.42), and SMS reminder ( RR 1.00; 95% CI 0.79–1.26; RR 0.87; 95% CI 0.81-0.94; OR 1.45; 95% CI 0.81-2.56; RR 0.97; 95% CI 0.88-1.07; RR 0.76; 95% CI 0.18-3.28). In terms of treatment success, phone calls (RR 1.30; 95% CI 1.07-1.59) and SMS reminders (OR 2.472; 95% CI 1.133-5.434) positively affected superior treatment outcomes. However, other studies found that SMS reminders were ineffective on the cure rate (OR 1.06; 95% CI 0.65-1.73; RR 1.05; 95% CI 0.62-1.76) and smear conversion outcomes (RR 1.00; 95% CI 0.90–1.12).

Conclusions:

Although various intervention effects were found in our study, DHT can be a promising approach in improving medication adherence and treatment outcomes. Considering individual factors of non-adherence to medication, developing DHT intervention with personalized feedback is needed to have a consistent and positive effect on medication adherence and treatment outcome among TB patients. Clinical Trial: n/a


 Citation

Please cite as:

Ridho A, Alfian SD, van Boven J, Levita J, Aki Yalcin E, Le L, Alffenaar JW, Hak E, Abdulah R, Pradipta IS

Digital Health Technologies to Improve Medication Adherence and Treatment Outcomes in Patients With Tuberculosis: Systematic Review of Randomized Controlled Trials

J Med Internet Res 2022;24(2):e33062

DOI: 10.2196/33062

PMID: 35195534

PMCID: 8908199

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.